US Stock MarketDetailed Quotes

LVCLF ALGORAE PHARMACEUTICALS LTD

Watchlist
  • 0.010
  • 0.0000.00%
15min DelayClose Sep 9 16:00 ET
17.34MMarket Cap-10275P/E (TTM)

ALGORAE PHARMACEUTICALS LTD Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
Total revenue
-67.57%3.17K
9.77K
Operating revenue
----
----
----
----
-67.57%3.17K
--9.77K
Cost of revenue
Gross profit
-67.57%3.17K
9.77K
Operating expense
3.32%2.2M
-10.38%2.13M
4.08%2.38M
-27.87%2.28M
-24.12%3.17M
4.17M
Selling and administrative expenses
--1.48M
----
----
----
----
----
-General and administrative expense
--1.48M
----
----
----
----
----
Research and development costs
-82.74%226.07K
-10.49%1.31M
-9.08%1.46M
-32.49%1.61M
-28.39%2.38M
--3.33M
Depreciation amortization depletion
----
-25.03%557
-84.45%743
-71.65%4.78K
-67.78%16.85K
--52.3K
-Depreciation and amortization
----
-25.03%557
-84.45%743
-71.65%4.78K
-67.78%16.85K
--52.3K
Other operating expenses
-39.91%492.69K
-10.19%819.89K
36.34%912.92K
-12.51%669.61K
-3.23%765.32K
--790.89K
Operating profit
-3.32%-2.2M
10.38%-2.13M
-4.08%-2.38M
27.80%-2.28M
24.01%-3.16M
-4.16M
Net non-operating interest income expense
197.98%125.2K
1,133.95%42.02K
-55.20%3.41K
-86.33%7.6K
-54.88%55.61K
123.25K
Non-operating interest income
197.98%125.2K
1,133.95%42.02K
-55.20%3.41K
-86.33%7.6K
-54.88%55.61K
--123.25K
Other net income (expense)
0.70%-20.04K
-3,360.10%-20.18K
-99.83%619
-79.04%365.79K
242.65%1.74M
509.26K
Special income (charges)
---2.11K
----
---12.31K
----
---148.2K
----
-Gain on sale of property,plant,equipment
---2.11K
----
---12.31K
----
---148.2K
----
Other non- operating income (expenses)
11.15%-17.93K
-256.12%-20.18K
-96.47%12.93K
-80.68%365.79K
271.75%1.89M
--509.26K
Income before tax
0.57%-2.1M
11.15%-2.11M
-24.49%-2.37M
-41.63%-1.91M
61.31%-1.35M
-3.48M
Income tax
0
0
6.77%-414.73K
-18.02%-444.86K
-27.27%-376.92K
-296.15K
Net income
0.57%-2.1M
-7.68%-2.11M
-34.01%-1.96M
-50.81%-1.46M
69.56%-968.47K
-3.18M
Net income continuous Operations
0.57%-2.1M
-7.68%-2.11M
-34.01%-1.96M
-50.81%-1.46M
69.56%-968.47K
---3.18M
Minority interest income
Net income attributable to the parent company
0.57%-2.1M
-7.68%-2.11M
-34.01%-1.96M
-50.81%-1.46M
69.56%-968.47K
-3.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
0.57%-2.1M
-7.68%-2.11M
-34.01%-1.96M
-50.81%-1.46M
69.56%-968.47K
-3.18M
Basic earnings per share
18.75%-0.0013
26.37%-0.0016
11.45%-0.0022
-52.99%-0.0025
69.65%-0.0016
-0.0053
Diluted earnings per share
18.75%-0.0013
26.37%-0.0016
11.45%-0.0022
-52.99%-0.0025
69.65%-0.0016
-0.0053
Dividend per share
Currency Unit
AUD
AUD
AUD
AUD
AUD
AUD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019
Total revenue -67.57%3.17K9.77K
Operating revenue -----------------67.57%3.17K--9.77K
Cost of revenue
Gross profit -67.57%3.17K9.77K
Operating expense 3.32%2.2M-10.38%2.13M4.08%2.38M-27.87%2.28M-24.12%3.17M4.17M
Selling and administrative expenses --1.48M--------------------
-General and administrative expense --1.48M--------------------
Research and development costs -82.74%226.07K-10.49%1.31M-9.08%1.46M-32.49%1.61M-28.39%2.38M--3.33M
Depreciation amortization depletion -----25.03%557-84.45%743-71.65%4.78K-67.78%16.85K--52.3K
-Depreciation and amortization -----25.03%557-84.45%743-71.65%4.78K-67.78%16.85K--52.3K
Other operating expenses -39.91%492.69K-10.19%819.89K36.34%912.92K-12.51%669.61K-3.23%765.32K--790.89K
Operating profit -3.32%-2.2M10.38%-2.13M-4.08%-2.38M27.80%-2.28M24.01%-3.16M-4.16M
Net non-operating interest income expense 197.98%125.2K1,133.95%42.02K-55.20%3.41K-86.33%7.6K-54.88%55.61K123.25K
Non-operating interest income 197.98%125.2K1,133.95%42.02K-55.20%3.41K-86.33%7.6K-54.88%55.61K--123.25K
Other net income (expense) 0.70%-20.04K-3,360.10%-20.18K-99.83%619-79.04%365.79K242.65%1.74M509.26K
Special income (charges) ---2.11K-------12.31K-------148.2K----
-Gain on sale of property,plant,equipment ---2.11K-------12.31K-------148.2K----
Other non- operating income (expenses) 11.15%-17.93K-256.12%-20.18K-96.47%12.93K-80.68%365.79K271.75%1.89M--509.26K
Income before tax 0.57%-2.1M11.15%-2.11M-24.49%-2.37M-41.63%-1.91M61.31%-1.35M-3.48M
Income tax 006.77%-414.73K-18.02%-444.86K-27.27%-376.92K-296.15K
Net income 0.57%-2.1M-7.68%-2.11M-34.01%-1.96M-50.81%-1.46M69.56%-968.47K-3.18M
Net income continuous Operations 0.57%-2.1M-7.68%-2.11M-34.01%-1.96M-50.81%-1.46M69.56%-968.47K---3.18M
Minority interest income
Net income attributable to the parent company 0.57%-2.1M-7.68%-2.11M-34.01%-1.96M-50.81%-1.46M69.56%-968.47K-3.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 0.57%-2.1M-7.68%-2.11M-34.01%-1.96M-50.81%-1.46M69.56%-968.47K-3.18M
Basic earnings per share 18.75%-0.001326.37%-0.001611.45%-0.0022-52.99%-0.002569.65%-0.0016-0.0053
Diluted earnings per share 18.75%-0.001326.37%-0.001611.45%-0.0022-52.99%-0.002569.65%-0.0016-0.0053
Dividend per share
Currency Unit AUDAUDAUDAUDAUDAUD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data